Hostname: page-component-5db58dd55d-ggg9q Total loading time: 0 Render date: 2026-06-01T01:20:09.390Z Has data issue: false hasContentIssue false

Glycerophospholipids in dairy cow health and longevity: a review

Published online by Cambridge University Press:  26 March 2026

David Bruce Sheedy*
Affiliation:
School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Camden, NSW, Australia Scibus, Camden, NSW, Australia
Helen Marie Golder
Affiliation:
School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Camden, NSW, Australia Scibus, Camden, NSW, Australia
Sergio Carlos Garcia
Affiliation:
School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Camden, NSW, Australia
Ian John Lean
Affiliation:
School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Camden, NSW, Australia Scibus, Camden, NSW, Australia
*
Corresponding author: David Bruce Sheedy, Email: davids@scibus.com.au
Rights & Permissions [Opens in a new window]

Abstract

This review examines the role glycerophospholipids (PL) in dairy cow health, with specific focus on phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and phosphatidylserine (PS). Increasing parity of cows is associated with lower concentrations of plasma PL that contain very long-chain omega-3 fatty acids, including docosahexaenoic acid and eicosapentaenoic acid, which are precursors for prostaglandin synthesis, and have anti-inflammatory roles. Low concentrations of these PL could plausibly contribute to the increased risk of disease, reproductive failure and mortality in older cows. The bioavailability and metabolism of fatty acids may differ among supplements that are predominately neutral lipids, such as triacylglycerol-rich oils, and those bound to PL including pasture, whole or ground oilseeds and fish meal. Hepatic lipidosis can occur during the transition period if there is insufficient very-low density lipoproteins (VLDL) production in the liver to transport lipids into blood circulation. The PC are the primary PL of VLDL and are produced by two main pathways in the liver, the cytidine diphosphate-choline pathway that uses choline as a substrate, and the PE N-methyltransferase pathway that uses PE and methyl-donors as substrates. Co-supplementation strategies that target both pathways may increase PC production over a one-pathway supplementation strategy. The PIs are phosphoinositides precursors, which have broad physiological roles including regulating inflammatory processes and may offer targets for novel treatment and management of disease. Both the PI and PE are precursors to endocannabinoids, important regulators of energy metabolism, immune function and reproduction in mammals. Early findings on the endocannabinoid system in transition dairy cows yielded results that diverge from non-ruminant models. The PS expression on cytoplasmic membranes signals apoptosis, coagulation and contributes to sperm–oocyte recognition. As lipidomic diagnostics become increasingly available, understanding the metabolism of PL will continue to develop and promises to offer novel strategies for optimising cattle health and longevity.

Information

Type
Review Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Hannah Dairy Research Foundation.
Figure 0

Figure 1. Glycerophospholipid metabolism depicting the most common pathways for production of phosphatidic acid, phosphatidylinositol (PI), phosphatidylcholine (PC), phosphatidylserine (PS) and phosphatidylethanolamine (PE). Enzymes are in grey boxes; fatty acyl chains are simplified as wavy chains esterified to the glycerol backbone. Phosphate and the specific head groups are depicted by the circled colored letter described in the bottom of the figure. Intracellular locations and lysophospholipids are not shown. ATGL – adipose triglyceride lipase; CDP – cytidine diphosphate; CDS – phosphatidate cytidylyltransferase; CEPT – choline/ethanolamine phosphotransferase; ChoK – choline kinase; CTP – cytidylyltransferase; DAGK – diacylglycerol kinase; DGAT – Diacylglycerol acyltransferases; EthK – ethanolamine kinase; GPAT – glycerol-3-phosphate acyltransferase; LPAAT – lysophosphatidic acid acyltransferases; PAP – phosphatidate phosphatase; PEMT – phosphatidylethanolamine-N-methyltransferase; PIS – phosphatidylinositol synthase; PLD – phospholipase D; PMT – Phosphoethanolamine methyltransferases; PSD – phosphatidylserine decarboxylase; PSS – phosphatidylserine synthase. Figure adapted from KEGG glycerophospholipid metabolism and Cayman Chemical lysophospholipid signaling poster (map00564) (Kanehisa et al., 2025; Cayman Chemical, 2020).

Figure 1

Figure 2. Phosphatidylcholine with palmitic at sn-1, alpha linolenic (n-3) at sn-2 and phosphocholine at sn-3. Common name: PC(16:0/18:3(6Z,9Z,12Z)). Image sourced from lipid maps: LMGP01010601.

Figure 2

Figure 3. The two main pathways for phosphatidylcholine (PC) production in the liver. The cytidine diphosphate (CDP)-choline pathway predominates, accounting for around 70% of PC production under normal conditions. The CDP-choline pathways progresses from choline (encircled green C), to phosphocholine, CDP-choline and PC. The alternative pathway to produce PC is the phosphatidylethanolamine-N-methyltransferase (PEMT) pathway, which consumes three S-adenosylmethionine (SAM) to convert phosphatidylethanolamine (PE) to PC. Choline may also contribute to the PEMT pathway via the transmethylation cycle. DMG – dimethylglycine; E (encircled purple) – ethanolamine; HCY – homocysteine; mTHF – methyltetrahydrofolate; P (encircled red) – Phosphate; SAH – S-adenosylhomocysteine; THF – tetrahydrofolate.

Figure 3

Figure 4. Phosphatidylethanolamine with stearic acid at sn-1, docosahexaenoic acid at sn-2 and phosphoethanolamine at sn-3. Common name: PE[18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)]. Image sourced from lipid maps: LMGP02010094.

Figure 4

Figure 5. Phosphatidylinositol with stearic acid at sn-1, arachidonic acid (n-6) at sn-2 and phospho-(1’-myo-inositol) at sn-3. Common name: PI(18:0/20:4(5Z,8Z,11Z,14Z)). Image sourced from lipid maps: LMGP06010010.

Figure 5

Figure 6. ‘Argranoff's turtle’ is a useful visual mnemonic for inositol. Using the D numbering convention, carbons are numbered anticlockwise beginning with turtle's right-flipper. The turtle is ‘right-handed’ and so is esterified to the phosphate group of phosphatic acid. The turtle's head is raised (hydroxyl group is axial) and the remaining limbs and tail are flat (hydroxyl groups equatorial).

Figure 6

Figure 7. Phosphatidylserine with palmitic at sn-1, eicosapentaenoic acid at sn-2 and phosphoserine at sn-3. Common name: PS[16:0/20:5(5Z,8Z,11Z,14Z,17Z)). Image sourced from lipid maps: LMGP03010902.